A short survey of dengue protease inhibitor development in the past 6 years (2015–2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases

Dengue remains a disease of significant concern, responsible for nearly half of all arthropod-borne disease cases across the globe. Due to the lack of potent and targeted therapeutics, palliative treatment and the adoption of preventive measures remain the only available options. Compounding the pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Murtuja, Sheikh, Shilkar, Deepak, Sarkar, Biswatrish, Sinha, Barij Nayan, Jayaprakash, Venkatesan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450225/
https://www.ncbi.nlm.nih.gov/pubmed/34601454
http://dx.doi.org/10.1016/j.bmc.2021.116415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450225/
https://www.ncbi.nlm.nih.gov/pubmed/34601454
http://dx.doi.org/10.1016/j.bmc.2021.116415

Ejemplares similares